Clinical Trials Browser

Constriction, Pathologic, Lymphoma, Follicular

NCT05637801 2026-02-05

Hope

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Clinical Trials

Evolut™ EXPAND TAVR II Pivotal Trial

Hope

Effectiveness and Safety Comparison of Lunaphil Ultra (Hyaluronic Acid, by Espad Pharmed Co.) Versus Juvederm Ultra 4® (Hyaluronic Acid, by Allergan Co.) in Nasolabial Folds (NLFs) Management

STARI

POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

APOLLO-EU

LONGSAFE

Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® L in Correcting Moderate or Severe Nasolabial Folds

The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies

ASV Therapy for Insomnia

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

Safety and Efficacy of the CarboClear Pedicle Screw System

A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses

Edwards EVOQUE Eos MISCEND Study

MargheRITA

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

BNICHAT

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours

A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

SRMR

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Safety and Efficacy Evaluation of CD19-UCART

Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

Spectral CT Clinical Trial

The Pilot Study of Medical Device-Neuclare for Patients With Mild Cognitive Disorder and Early Dementia

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

CAR-T Cells in the Treatment of Malignant Hematological Tumors

RESTORE

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma

RELIEF-1

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Overture

CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia

A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma

A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies

POST

CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

PARTNERII B